Max Healthcare Institute Limited (NSE:MAXHEALTH)
India · Delayed Price · Currency is INR 927.15
+31.65 (3.53%)
Nov 4, 2026, 3:29 PM IST
Max Healthcare Institute Stock Forecast
Stock Price Forecast
According to 28 analysts polled by S&P Global, Max Healthcare Institute stock has a consensus rating of "Buy" and an average price target of ₹1,140. The average 1-year stock price forecast is 22.94% higher than the current stock price, while the lowest is ₹825.00 (-11.02%) and the highest is ₹1,320 (+42.37%).
Price Target: ₹1,140 (+22.94%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Max Healthcare Institute stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 | Nov '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 12 | 12 | 13 | 12 | 13 | 13 |
| Buy | 7 | 8 | 8 | 8 | 8 | 8 |
| Hold | 3 | 3 | 3 | 3 | 3 | 3 |
| Sell | 3 | 3 | 3 | 3 | 3 | 3 |
| Strong Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Total | 26 | 27 | 28 | 27 | 28 | 28 |
Financial Forecast
Revenue This Year
116.68B
from 83.73B
Increased by 39.35%
Revenue Next Year
139.39B
from 116.68B
Increased by 19.46%
EPS This Year
18.65
from 15.18
Increased by 22.84%
EPS Next Year
23.12
from 18.65
Increased by 23.97%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is INR.